Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2010 4
2011 1
2012 1
2013 2
2014 1
2015 3
2016 2
2019 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of regular with NPH insulin vs. premix insulin in children and adolescents with type 1 diabetes in a resources-limited setting: a retrospective data analysis.
Sagna Y, Bagbila WPAH, Bognounou R, Ilboudo A, Sawadogo N, Kyelem CG, Guira O, Ouedraogo MS, Drabo JY. Sagna Y, et al. Among authors: drabo jy. J Pediatr Endocrinol Metab. 2023 Mar 13;36(5):447-450. doi: 10.1515/jpem-2022-0637. Print 2023 May 25. J Pediatr Endocrinol Metab. 2023. PMID: 36913487
Incidence, prevalence, and mortality of type 1 diabetes in children and youth in Burkina Faso 2013-2022.
Sagna Y, Bagbila WPAH, Sawadogo N, Savadogo PPC, Zoungrana L, Séré L, Yanogo ADR, Saloukou KEM, Zemba D, Zio GU, Zombre YT, Millogo R, Traoré S, Ilboudo A, Bognounou R, Ouedraogo NCJ, Nikiema P, Bengaly S, Gilberte Kyelem C, Guira O, Maniam J, Ogle GD, Ouedraogo MS, Drabo JY. Sagna Y, et al. Among authors: drabo jy. Diabetes Res Clin Pract. 2024 Jan;207:111086. doi: 10.1016/j.diabres.2023.111086. Epub 2024 Jan 3. Diabetes Res Clin Pract. 2024. PMID: 38181985
Features of Metabolic Syndrome and Its Associated Factors during Highly Active Antiretroviral Therapy in Ouagadougou (Burkina Faso).
Guira O, Tiéno H, Diendéré AE, Sagna Y, Diallo I, Yaméogo B, Zoungrana L, Yaméogo TM, Bognounou R, Drabo JY. Guira O, et al. Among authors: drabo jy. J Int Assoc Provid AIDS Care. 2016 Mar-Apr;15(2):159-63. doi: 10.1177/2325957415601503. Epub 2015 Aug 25. J Int Assoc Provid AIDS Care. 2016. PMID: 26307211 Free article.
HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina Faso.
Tebit DM, Sangaré L, Makamtse A, Yameogo S, Somlare H, Bado G, Kouldiaty BG, Sathiandee K, Tiba F, Sanou I, Ouédraogo-Traoré R, Zoungrana L, Diallo I, Drabo JY, Kräusslich HG. Tebit DM, et al. Among authors: drabo jy. J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):17-25. doi: 10.1097/QAI.0b013e318182d2bc. J Acquir Immune Defic Syndr. 2008. PMID: 18667925
The Modalities of Nonadherence to Highly Active Antiretroviral Therapy and the Associated Factors Related to Patients' Sociodemographic Characteristics and Their Caregiving Perceptions in Ouagadougou (Burkina Faso).
Guira O, Kaboré DS, Dao G, Zagré N, Zohoncon TM, Pietra V, Drabo JY, Simporé J. Guira O, et al. Among authors: drabo jy. J Int Assoc Provid AIDS Care. 2016 May;15(3):256-60. doi: 10.1177/2325957415616492. Epub 2015 Nov 13. J Int Assoc Provid AIDS Care. 2016. PMID: 26567225 Free article.
17 results